Dsm Managing Board

DSM Q2 nutrition profits slip 11% as key markets struggle

DSM Q2 nutrition profits slip 11% as key markets struggle

By Shane STARLING

Sales slipped 6% and net profits 11% in Q2 for DSM’s human and animal nutrition arm as adverse currency movements, a slow US vitamins and omega-3 food supplements market and the Asian botulism infant formula scare affected earnings.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All